PPCB vs REG · P/E 0.0, $3.9M cap vs P/E 34, $12.93B cap
Propanc Biopharma, Inc. Common Stock (PPCB) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
PPCB does not have a complete income-statement cache yet.
REG does not have a complete income-statement cache yet.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the PPCB and REG stock pages for the full models.
Not investment advice.